Imugene (IMU) EGM 2025 summary

Opening remarks and agenda

• Meeting opened with acknowledgment of traditional landowners and confirmation of quorum.

• Hybrid meeting format enabled both in-person and virtual participation, with instructions for voting and questions provided.

• Extraordinary General Meeting held on 20 August 2025, authorized by the Managing Director and CEO.

• Agenda included formal resolutions, a CEO presentation, and a Q&A session.

Specific resolutions to be voted on

• Ratification of prior issue of 68.2 million placement shares under ASX Listing Rule 7.1.

• Approval to issue up to 51.1 million placement attaching options at AUD 0.43, expiring March 2026.

• Approval to issue up to 45.4 million new shares and 34 million SPP attaching options under the SPP offer.

• Focus on updates and strategic direction for clinical programs.

Overview of voting outcomes

• Resolution 1: 92.3% in favor, overwhelmingly carried.

• Resolution 2: 91.6% in favor, overwhelmingly carried.

• Resolution 3: 91.35% in favor, overwhelmingly carried.

• Poll closed and results to be announced to the ASX.

• Key milestones and achievements highlighted for the next 12 months.